Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) has received certification from the Japan Analytical Instruments Manufacturers’ Association (JAIMA) and the Japan Scientific Instruments Association (JSIA) for one of its products under the 3rd Heritage Program of Legacy Analytical Instruments/Scientific Instruments. This certification was received for the CC-1001 automated hematology analyzer that Sysmex developed as the first such instrument in Japan for automatically measuring the number of white and red blood cells.
JAIMA and JSIA introduced a certification program in 2012 to recognize the heritage of analytical instruments and scientific instruments that communicate, as a cultural heritage for future generations, the analytical technologies/instruments and scientific instruments that have contributed in an important way to the lives, economy, education and culture of the Japanese populace. To date, 35 items have earned this recognition.
In the 3rd Heritage Program of Legacy Analytical Instruments/Scientific Instruments, Sysmex received certification for its automated hematology analyzer CC-1001, which it pioneered the development of in Japan in 1963.
Hematology, which measures and analyzes the number and size of red and white blood cells, plays an important role in diagnosing health, as well as the diagnosis and treatment of illness. To count the number of blood cells, Sysmex used micromachining technology which encloses opposing electrodes with a diameter of 80 microns into an orifice with a diameter of 100 microns, and developed the world’s first hematology analyzer employing an innovative technology called the conductance method. This method detected tiny changes in conductance as microparticles flowed through the fluid medium through the orifice as high frequencies were applied to the electrodes at opposite ends of the orifice.
For nearly a century, hematology in Japan had involved visual assessments by clinical professionals using microscopes. The CC-1001, which allowed blood cells to be measured automatically, was widely adopted throughout Japan.
This development led to increased measurement precision, reduced personnel requirements for testing and contributed to faster reporting of test results. The CC-1001 also helped to meet the growing testing demand stemming from Japan’s 1961 introduction of a national healthcare system.
The high-frequency technique based on the principle of detecting a change in conductance—the innovative technology that led to the development of the CC-1001—prompted the development and application of functions for classifying and analyzing white blood cells and supported Sysmex’s development of hematology analyzers. We have also created automatic transport systems, which improve the speed and safety of testing environments. These developments, plus the application of high-value-added testing parameters, have earned our leading-edge technologies a global reputation. As a result, Sysmex has garnered the world’s leading market share in the hematology field. We contribute substantially to healthcare throughout the world, working with healthcare institutions in more than 170 countries.
Sysmex expects to receive its certificate for the CC-1001 at JASIS 2014 (formerly called the Analytical & Scientific Instruments Show), which is to be held in Makuhari Messe on September 3, 2014.
Going forward, through research and development to enhance testing quality and efficiency further, Sysmex aims to meet the rise in testing demand and increasingly diverse needs in regions around the world, thereby contributing to the advancement of healthcare.
Automated Hematology Analyzer CC-1001
- Information contained in the press release is current as of the date of the announcement,
but may be subject to change without prior notice.